Machine Learning‐Guided Repositioning of a SARS‐CoV‐2‐Targeting Molecular Series as Cruzain Inhibitors
ChemMedChem · 2026
DOI: 10.1002/cmdc.202500630 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2026. Verfasst von Rafael F Lameiro und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medicinal and Biological Chemistry Group, São Carlos Institute of Chemistry, University of São Paulo, Avenida Trabalhador Sancarlense, 400, São Carlo…. Hauptthemen laut MEDLINE: Cysteine Endopeptidases, Machine Learning, SARS-CoV-2, Drug Repositioning. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil.
Abstract (Originalsprache)
Drug repurposing and repositioning are concepts that involve identifying alternative therapeutic uses for existing drug candidates or molecular series. During the COVID‐19 pandemic, hundreds of antivirals were developed, many of which remain unexplored for other diseases. Concurrently, machine learning (ML) has become a valuable tool in early drug discovery for screening the most promising compounds for a target. In this work, an ExtraTrees ML model is developed to predict inhibitory activity against cruzain, the main cysteine protease of Trypanosoma cruzi , the causative agent of Chagas disease. The model is used to screen a proprietary library of peptidomimetic compounds originally designed to target SARS‐CoV‐2 M pro and human cathepsin L. High‐affinity cruzain inhibitors are identified, some containing P1 moieties not previously reported in cruzain inhibitors, expanding the known chemical space for this target. Selected hits are validated using isothermal titration calorimetry and some compounds display more favorable enthalpic and entropic contributions to binding than similar peptidomimetic nitrile‐based inhibitors. Notably, this is achieved without highly lipophilic R‐groups, preserving drug‐like properties. This work also highlights how compound libraries derived from global health efforts can be effectively repurposed for neglected tropical diseases with ML models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medicinal and Biological Chemistry Group, São Carlos Institute of Chemistry, University of São Paulo, Avenida Trabalhador Sancarlense, 400, São Carlos, SP, 13566-590, Brazil.
ORCID-Profile: Rafael F Lameiro, Luiz F Barbosa, Felipe Cardoso Prado Martins, Carlos A Montanari
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil
- FAPESP
- CNPq
Zitieren
APA
Lameiro, R. F., Barbosa, L. F., Cardoso, E. R., Ho, B. S., Martins, F. C. P., de Melo, B. C., Rosini, F., Shamim, A., Souza, P. M., de Souza, W. F., & Montanari, C. A. (2026). Machine Learning‐Guided Repositioning of a SARS‐CoV‐2‐Targeting Molecular Series as Cruzain Inhibitors. ChemMedChem. https://doi.org/10.1002/cmdc.202500630
Vancouver
Lameiro RF, Barbosa LF, Cardoso ER, Ho BS, Martins FCP, de Melo BC, et al. Machine Learning‐Guided Repositioning of a SARS‐CoV‐2‐Targeting Molecular Series as Cruzain Inhibitors. ChemMedChem. 2026. doi:10.1002/cmdc.202500630
BibTeX
@article{Lameiro2026,
author = {Lameiro, Rafael F and Barbosa, Luiz F and Cardoso, Evelin R and Ho, Beatriz Siqueira and Martins, Felipe Cardoso Prado and de Melo, Bruna C and Rosini, Fabiana and Shamim, Anwar and Souza, Priscila M and de Souza, Wellington Falcão and Montanari, Carlos A},
title = {Machine Learning‐Guided Repositioning of a SARS‐CoV‐2‐Targeting Molecular Series as Cruzain Inhibitors},
journal = {ChemMedChem},
year = {2026},
doi = {10.1002/cmdc.202500630}
}
EUVIMED